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Abstract
Diabetes and stress stimulate hippocampal 5-HT synthesis, metabolism and release. The present study was carried
out to find the effects of insulin, Aegle marmelose alone and in combination with pyridoxine on the hippocampal
5-HT, 5-HT2A receptor subtype, gene expression studies on 5-HT2A, 5-HTT, INSR, immunohistochemical studies and
elevated plus maze in streptozotocin induced diabetic rats. 5-HT content showed a significant decrease (p < 0.001)
and a significant increase (p < 0.001) in 5-HIAA in hippocampus of diabetic rats compared to control. 5-HT receptor
binding parameters Bmax and Kd showed a significant decrease (p < 0.001) whereas 5-HT2A receptor binding para-
meters Bmax showed a significant decrease (p < 0.001) with a significant increase (p < 0.05) in Kd in hippocampus
of diabetic rats compared to control. Gene expression studies of 5-HT2A, 5-HTT and INSR in hippocampus showed a
significant down regulation (p < 0.001) in diabetic rats compared to control. Pyridoxine treated in combination
with insulin and A. marmelose to diabetic rats reversed the 5-HT content, Bmax ,K d of 5-HT, 5-HT2A and gene
expression of 5-HT2A, 5-HTT and INSR in hippocampus to near control. The gene expression of 5-HT2A and 5-HTT
were confirmed by immunohistochemical studies. Behavioural studies using elevated plus maze showed that sero-
tonin through its transporter significantly increased (p < 0.001) anxiety-related traits in diabetic rats which were
corrected by combination therapy. Our results suggest that pyridoxine treated in combination with insulin and A.
marmelose has a role in the regulation of insulin synthesis and release, normalising diabetic related stress and anxiety
through hippocampal serotonergic function. This has clinical significance in the management of diabetes.
Background
Diabetes is associated with several adverse effects on
the brain, which results primarily from direct conse-
quences of chronic hyperglycemia. Diabetes induces
impairments in hippocampal synaptic plasticity, neuro-
genesis and associated cognitive deficits. Intrahippo-
campal insulin [1] or activation of insulin signalling
pathways [2] block the effects of stress on learning and
memory. In control rats, hippocampus dependent
learning is correlated with a decrease in extracellular
glucose, and intrahippocampal injection of glucose
improves performance [3]. Learning-induced changes
in hippocampal glucose metabolism have been demon-
strated in diabetic rats [4]. Hippocampus is particularly
susceptible to the negative consequences of diabetes
[5]. Individuals with diabetes suffer from reduced
motor activity and are at increased risk of dementia
and cognitive dysfunction [6]. 5-HT innervations of
the hippocampus originate from the raphe nuclei in
the midbrain [7]. 5-HT is released into the extracellu-
lar space and via synapses [8]. Direct effects of 5-HT
on principal cells occur through its release in extracel-
lular space. 5-HT2A receptors are involved in a diver-
sity of physiological functions such as the control of
nociception, motor behaviour, endocrine secretion,
thermoregulation and modulation of appetite [9].
There is a need to explore diabetes and its complica-
tions to reduce the mechanisms by which oxidative
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expand the treatment, Aegle marmelose (L.) Correa
ex Roxb. an ayurvedic medicinal tree, growing throughout
t h ed e c i d u o u sf o r e s to fI n d i ai sr e p o r t e dt oh a v ea n t i -
diabetic effect in rats. In the brain, L-tryptophan is
converted to 5-HT in the presence of the co-enzyme
pyridoxine [10]. 5-HT decrease has been reported in
hypothyroidism and hypertension [9,11]. Pyridoxine
supplementation is used for cognitive impairment or
dementia [12].
In the current study, the effect of leaf extract of Aegle
marmelose and insulin alone and in combination with
pyridoxine in diabetic rats on the hippocampal 5-HT
through 5HT2A receptor subtype - 5HT2A, 5-HTT and
INSR gene expression and immunohistochemical studies
using confocal microscope was carried out. Behavioural
studies using elevated plus maze was also done to eluci-
date the anxiety-related traits in these rats.
Materials and methods
Animals
Adult Male Wistar rats 200 - 250 g body weight were
purchased from Amrita Institute of Medical Sciences,
Cochin and used for all experiments. They were housed
in separate cages under 12 hours light and 12 hours
dark periods and were maintained on standard food pel-
lets, water ad libitum and room temperature. They were
housed for 1 to 2 weeks before experiments were per-
formed. All animal care and procedures were in accor-
dance with Institutional and National Institute of Health
guidelines.
Induction of Diabetes
The animals were randomly divided into control (C),
diabetic (D), insulin treated diabetic (D+I), diabetic
treated with insulin + pyridoxine (DIP), diabetic trea-
ted with pyridoxine alone (D+P), diabetic treated with
Aegle marmelose (D+A) and diabetic treated with Aegle
marmelose + pyridoxine (DAP). Each group consisted
of 6-8 animals. Values are mean ± S.E.M of 4-6 rats in
each group. Diabetes was induced by a single intrafe-
moral dose (55 mg/kg body weight) of streptozotocin
prepared in citrate buffer, pH 4.5 [13]. The D+I and
DIP groups received a daily dose (1 Unit/kg body
weight) of Lente and Plain insulin. Pyridoxine injected
was 100 mg/kg body weight [14]. Aqueous extract of
Aegle marmelose was given orally in the dosage of 1 g/
Kg body weight [15] at 24 hour intervals. The experi-
mental rats were sacrificed by decapitation after 15
days treatment. The hippocampus was dissected out
quickly over ice according to the procedure of [16].
The tissues were stored at -80°C until assay. Glucose
was measured by GOD-POD glucose estimation kit
(Biolab Diagnostics Pvt. Ltd).
Plant material and Preparation of extract
Specimen of Aegle marmelose were collected and vou-
cher specimens was deposited at herbarium of Centre
for Neuroscience, Cochin University of Science and
T e c h n o l o g y ,C o c h i n ,K e r a l a ,I n d i a .F r e s hl e a v e so fAegle
marmelose were air dried in shade and powdered. 10 g
of leaf powder was mixed with 100 ml of distilled water
and stirred for 2 hr. It was kept overnight at 4°C. The
supernatant was collected and evaporated to dryness fol-
lowed by lyophylization in Yamato, Neocool, Japan
lyophilizer. This was used as the crude leaf extract to
study the antidiabetic effect in streptozotocin induced
diabetes.
Quantification of Serotonin
Serotonin content was assayed according to Paulose et
al. [17]. The cerebral cortex and brain stem of the
experimental groups of rats was homogenized in 0.4 N
perchloric acid. The homogenate was centrifuged at
5000 × g for 10 min at 4°C in a Sigma 3K30 refrigerated
centrifuge and the clear supernatant was filtered
through 0.22 μm HPLC grade filters and used for HPLC
analysis.
Serotonin (5-HT) and 5-hydroxy indole acetic acid
(5-HIAA) contents were determined using high perfor-
mance liquid chromatography integrated with an elec-
trochemical detector (HPLC-ECD) (Waters, USA) fitted
with CLC-ODS reverse phase column of 5 μm particle
size. The mobile phase consisted of 50 mM sodium
phosphate dibasic, 0.03 M citric acid, 0.6 mM sodium
octyl sulphonate, 0.1 mM EDTA and 15% methanol.
The pH was adjusted to 3.25 with orthophosphoric acid,
filtered through the 0.22 μm filter (Millipore) and
degassed. A Waters model 515, Milford, USA, pump
was used to deliver the solvent at a rate of 1 ml/minute.
The neurotransmitters and their metabolites were iden-
tified by amperometric detection using an electrochemi-
cal detector (Waters, model 2465) with a reduction
potential of +0.80 V.
5-HT Receptor Binding Studies Using [
3H]
5-Hydroxytryptamine
5-HT receptor assay was done using [
3H] 5-hydroxy-
tryptamine binding in crude synaptic membrane pre-
parations of hippocampus by the modified method of
[18]. Crude membrane preparation was suspended in 50
mM Tris-HCl buffer, pH 8.5, containing 1.0 μM paragy-
line. The incubation mixture contained 0.3-0.4 mg pro-
tein. In the saturation binding experiments, assays were
done using different concentrations i.e., 1.0 nM-30 nM
of [
3H] 5-HT was incubated with and without excess of
unlabelled 10 μM 5-HT. Tubes were incubated at 37°C
for 15 min. and filtered rapidly through GF/B filters
(Whatman). The filters were washed quickly by three
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buffer, pH 8.5. Bound radioactivity was counted with
cocktail-T in a Wallac 1409 liquid scintillation counter.
5-HT2A Receptor Binding Studies Using [
3H] Ketanserin
5-HT2A receptor assay was done using [
3H] Ketanserin
binding in crude synaptic membrane preparations of
hippocampus by the modified method of [19]. Crude
membrane preparation was suspended in 50 mM Tris-
HCl buffer, pH 7.6. The incubation mixture contained
0.3-0.4 mg protein. In the saturation binding experi-
ments using different concentrations i.e., 0.1 nM - 2.5
nM of [
3H] Ketanserin was incubated with and without
excess of unlabelled 10 μM Ketanserin. Tubes were
incubated at 37°C for 15 minutes and filtered rapidly
through GF/B filters (Whatman). The filters were
washed quickly by three successive washing with 5.0 ml
of ice cold 50 mM Tris buffer, pH 7.6. Bound radioac-
tivity was counted with cocktail-T in a Wallac 1409
liquid scintillation counter. Protein was measured by the
method of Lowry et al. [20] using bovine serum albumin
as standard.
Receptor data analysis
T h ed a t aw e r ea n a l y s e da c c o r d i n gt oS c a t c h a r d[ 2 1 ] .
The binding parameters, maximal binding (Bmax)a n d
equilibrium dissociation constant (Kd), were derived by
linear regression analysis.
Real -Time PCR Assay using 5-HT2A, 5-HTT and INSR
RNA was isolated from the hippocampus of experimen-
tal rats using the Tri reagent (MRC, USA). Total cDNA
synthesis was performedu s i n gA B IP R I S Mc D N A
archive kit in 0.2 ml microfuge tubes. The reaction mix-
ture of 20 μlc o n t a i n e d0 . 2μgt o t a lR N A ,1 0×R Tb u f -
fer, 25 × dNTP mixture, 10 × random primers,
MultiScribe RT (50 U/μl) and RNase free water. The
cDNA synthesis reactions were carried out at 25°C for
10 minutes and 37°C for 2 hours using an Eppendorf
Personal Cycler. Total cDNA synthesis was performed
using ABI PRISM cDNA Archive kit. Real-Time PCR
assays were performed in 96-well plates in ABI 7300
Real-Time PCR instrument (Applied Biosystems). PCR
analyses were conducted with gene-specific primers and
fluorescently labelled Taqman 5-HT receptor subtype
(5HT2A; Rn01468302_m1), 5-HT transporter (5HTT;
Rn00564737_m1) and Insulin receptor (INSR;
Rn00567070)) (designed by Applied Biosystems). Endo-
genous control (b-actin) was labelled with a report dye
(VIC). The real-time data were analyzed with Sequence
Detection Systems software version 1.7. All reactions
were performed in duplicate.
The ΔΔCT method of relative quantification was used
to determine the fold change in expression. This was
done by first normalizing the resulting threshold cycle
(CT) values of the target mRNAs to the CT values of
the internal control b-actin in the same samples (ΔCT =
CTTarget -C T b-actin). It was further normalized with the
control (ΔΔCT = ΔCT - CTControl). The fold change in
expression was then obtained (2
-ΔΔCT).
5-HT2A and 5-HTT Expression Studies in the Hippocampus
of control and experimental rats using confocal
microscope
Control and experimental rats were anesthetized with
ether. The rat was transcardially perfused with PBS, pH
7.4, followed by 4% paraformaldehyde in PBS [22]. After
perfusion the brains were dissected and immersion fixed
in 4% paraformaldehyde for 1 hr and then equilibrated
with 30% sucrose solution in 0.1 M PBS, pH 7.0. 40 μm
sections were cut using Cryostat (Leica, CM1510 S).
The sections were treated with PBST (PBS in 0.01%
Triton X-100) for 20 min. Brain slices were incubated
o v e r n i g h ta t4 ° Cw i t he i t h er rat primary antibody for
5-HT2A (No: RA24288 BD PharmenginTM, diluted in
PBST at 1: 500 dilution) and 5HTT (No: AB9726 Chemi-
con Temecula, diluted in PBST at 1: 500 dilution). After
overnight incubation, the brain slices were rinsed with
PBST and then incubated with appropriate secondary anti-
body of either FITC (No: AB7130F, Chemicon, diluted in
PBST at 1: 1000). The sections were observed and photo-
graphed using confocal imaging system (Leica SP 5).
Elevated plus maze
The elevated plus-maze is a widely used animal model
of anxiety that is based on two conflicting tendencies;
the rodents drive to explore a novel environment and its
aversion to heights and open spaces. Four arms were
arranged in the shape of a cross. Two arms had side
walls and an end wall (“closed arms”)-t h et w oo t h e r
arms had no walls (“open arms”). The open arms were
surrounded by small ledges to prevent the animal from
falling from the maze. The maze was fastened to a light-
weight support frame. Thus “anxious” animals spent
most of the time in the closed arms while less anxious
animals explored open areas longer.
Procedure
Animals were placed individually into the center of ele-
vated plus-maze consisting of two open arms (38 L × 5
W cm) and two closed arms (38 L × 5 W × 15 H cm),
with a central intersection (5 cm × 5 cm) elevated 50
cm above the floor. Behaviour was tested in a dimly lit
room with a 40 W bulb hung 60 cm above the central
part of the maze. The investigator sitting approximately
2 m apart from the apparatus observed and detected the
movements of the rats for a total of 5 minutes. The
experimental procedure was similar to that described by
[23]. During the 5 min test period the following
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changes of the experimental rats using elevated plus-
maze: open arm entry, closed arm entry, percentage arm
entry, total arm entry, time spent in open arm, time
spent in closed arm, percentage of time spent in open
arm [24,25]. An entry was defined as entering with all
four feet into one arm. A decrease in open arm entries
and decrease in time spent in the open arms is indica-
tive of anxiogenic activity shown by experimental rats.
Statistical Analysis
T h ee q u a l i t yo fa l lt h eg r o u p sw a st e s t e db yt h ea n a l y s i s
of variance (ANOVA) technique for different values of p.
Further the pair wise comparisons of all the experimental
groups were studied using Students-Newman-Keuls test
at different significance levels. The testing was performed
using GraphPad Instat (Ver. 2.04a, San Diego, USA)
computer program.
Results
Estimation of blood glucose
Blood glucose level of all rats before streptozotocin
administration was within the normal range. Streptozo-
tocin administration led to a significant increase
(p < 0.001) in blood glucose level of diabetic rats com-
pared to control rats. Treatment with pyridoxine alone
and in combination with Aegle marmelose and insulin in
diabetic rats was able to significantly reduce (p < 0.001)
the increased blood glucose level to near the control
value compared to diabetic group (Figure-1).
Serotonin and Its Metabolites Content in Hippocampus of
control and experimental rats
There was a significant decrease (p < 0.001) in 5-HT
content in hippocampus of diabetic rats compared to
control rats. The decreased 5-HT content was signifi-
cantly reversed the D+P (p < 0.01), D+I (p < 0.01), DIP (p
< 0.001), D+A (p < 0.01) and DAP (p < 0.001) to near
control in diabetic rats treated with pyridoxine alone and
in combination with insulin and Aegle marmelose leaf
extract. The 5-HIAA in the hippocampus was signifi-
cantly increased (p < 0.001) in diabetic rats compared to
control. The increased 5-HIAA content was signifi-
cantly reversed in D+P (p < 0.01), D+I (p < 0.01), DIP
(p < 0.001), D+A (p < 0.01) and DAP (p < 0.001) to near
control in diabetic rats treated with pyridoxine alone and
in combination with insulin and Aegle marmelose leaf
extract (Table-1).
5-HT and 5-HT2A receptor binding in the hippocampus of
control and experimental rats
Scatchard analysis using [
3H] 5-HT binding against
5-HT showed that the Bmax decreased significantly
(p < 0.001) in the hippocampus of diabetic rats with sig-
nificant increase (p < 0.001) in the affinity. Treatment
with pyridoxine alone and in combination with Aegle
marmelose and insulin in diabetic rats reversed the Bmax
and Kd to near control compared to diabetic group
(Table-2, Figure-2a, b).
Scatchard analysis using [
3H] Ketanserin binding
against ketanserin showed that the Bmax decreased
Figure 1 Representative graph showing Blood glucose (mg/dl) level in Control and Experimental rats. Values are mean ± S.E.M of 4-6
rats in each group. Each group consists of 6-8 rats.
a p < 0.001 when compared to control;
b p < 0.001 when compared to diabetic group;
c p
< 0.001 when compared with initial reading.
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rats with significant increase( p<0 . 0 0 1 )i nt h ea f f i n i t y .
Treatment groups reversed the Bmax of D+I (p < 0.001),
DIP (p < 0.001), D+A (p < 0.001) and DAP (p < 0.001)
to near control compared to diabetic group (Table-3,
Figure-3a, b).
Real Time-PCR analysis of 5-HT2A, 5-HTT and INSR
receptor expression in the hippocampus of control and
experimental rats
Real Time-PCR analysis showed that the 5-HT2A and
5-HTT mRNA showed a significant down regulation
(p < 0.001) in diabetic rats when compared to control
and it was (p < 0.001) reversed to near control level on
treatment with pyridoxine alone and in combination
therapy with Aegle marmelose and insulin in diabetic
rats (Figure-4, 5).
Real Time-PCR analysis showed that the INSR
mRNA showed a significant down regulation (p <
0.001) in diabetic rats when compared to control and
it was (p < 0.001) reversed to near control level on
treatment with pyridoxine alone and in combination
therapy with Aegle marmelose and insulin in diabetic
rats (Figure-6).
Elevated plus maze test in the control and experimental
rats
(i) Behavioural response in streptozotocin induced dia-
betic Rats: Effect of insulin and pyridoxine treatment on
open and closed arm entry in elevated plus- maze test
The experimental groups showed a significant increase
in the attempt taken for open arm entry- D (p < 0.001)
compared to C. D+I (p < 0.001), D+P (p < 0.01), DIP
(p < 0.001), D+A(p < 0.001) and DAP (p < 0.001) trea-
ted groups showed the open arm entry to near control
(Figure-7).
There was a significant increase (p < 0.001) in the
number of entries made into closed arm by D compared
to C. D+I (p < 0.001), D+P (p < 0.01), DIP (p < 0.001),
D+A (p < 0.001) and DAP (p < 0.001) treated groups
showed the open arm entry to near control (Figure-7, 8).
(ii) Behavioural response in streptozotocin induced
diabetic Rats: Effects insulin and pyridoxine treatment
on time spent in open and closed arms in Elevated plus-
maze test
There was a significant decrease in time spent in open
arm by D (p < 0.001) compared to C (Figure-7). Time
spent in closed arm showed a significant increase in D
(p < 0.001) when compared to C. D+I (p < 0.001), D+P
(p < 0.01), DIP (p < 0.001), D+A (p < 0.001) and DAP
(p < 0.001) treated groups showed the time spent in
open and closed arms near to control (Figure-8).
5-HT2A and 5-HTT antibody staining in control and
experimental groups of rats
The 5-HT2A receptor antibody staining in the hippo-
campus showed significant decrease (p < 0.001) in the
5-HT2A receptor in diabetic rats compared to control.
There was significant reversal of 5-HT2A receptor to
near control level in D+I (p < 0.001), D+P (p < 0.05),
DIP (p < 0.001), D+A (p < 0.001) and DAP (p < 0.001)
Table 1 Serotonin and metabolites in the hippocampus of control and experimental rats
Experimental Groups 5-HT
(nmoles/g wet wt. of tissue)
5HIAA
(nmoles/g wet wt. of tissue)
5-HIAA/
5-HT
Control 1.56 ± 0.27 1.94 ± 0.22 1.24 ± 0.23
Diabetic 0.89 ± 0.29
a 2.93 ± 0.31
a 3.29 ± 0.28
a
Diabetic+Insulin 1.07 ± 0.19
a, b 2.29 ± 0.20
a, b 2.14 ± 0.20
a
Diabetic+Pyridoxine 0.98 ± 0.33
a, b 2.91 ± 0.36
a 2.96 ± 0.33
a
Diabetic+Insulin+Pyridoxine 1.45 ± 0.35
c 1.53 ± 0.29
c 1.05 ± 0.31
c
Diabetic+A. marmelose 1.10 ± 0.23
a, b 2.73 ± 0.24
a, b 2.48 ± 0.21
a
Diabetic+A. marmelose+Pyridoxine 1.59 ± 0.22
c 1.66 ± 0.22
c 1.04 ± 0.21
c
Values are mean ± S.E.M of 4-6 separate experiments. Each group consists of 6-8 rats.
a p < 0.001 when compared to control;
b p < 0.01,
c p < 0.001 when compared to diabetic group.
Table 2 [
3H] 5-Hydroxytryptamine binding parameters in
the hippocampus of control and experimental rats
Experimental Groups Bmax
(fmoles/mg protein)
Kd (nM)
Control 212.5 ± 2.11 3.22 ± 0.54
Diabetic 72.4 ± 3.21
a 1.94 ± 0.41
a
Diabetic + Insulin 62.8 ± 2.06
a 1.40 ± 0.29
a
Diabetic + Pyridoxine 148.4 ± 2.33
a, c 2.60 ± 0.49
b
Diabetic + Insulin+
Pyridoxine
196.0 ± 1.43
c 3.20 ± 0.17
c
Diabetic + A. marmelose 140.1 ± 4.33
a, c 2.57 ± 1.42
b
Diabetic + A. marmelose +
Pyridoxine
186.4 ± 2.42
c 3.05 ± 1.31
c
Values are mean ± S.E.M of 6-8 separate experiments. Each group consists of
6-8 rats.
a p < 0.001,
b p < 0.05 when compared to control group;
c p < 0.001 when
compared to diabetic group.
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Figure 2 a, b Representative graph showing Scatchard analysis of [
3H] 5-HT binding against 5-HT in the hippocampus of control and
experimental rats.B max – Maximal Binding (fmol/mg protein), Kd – dissociation constant (nM). Values are Mean ± S.E.M. of 4-6 separate
experiments. Each group consists of 6-8 rats.
a p < 0.001,
b p < 0.05 when compared to control group;
c p < 0.001 when compared to diabetic
group. Incubation was done with 1.0 nM-30 nM at 37 °C of [
3H] 5-HT in a total incubation volume of 250 μl. 10 μM unlabelled 5-HT was used to
determine the nonspecific binding. The reaction was stopped by rapid filtration through GF/B filters using ice cold Washing Buffer pH 8.5. Bound
radioactivity was counted with cocktail-T in a Wallac 1409 liquid scintillation counter.
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and in combination therapy with insulin and Aegle
marmelose compared to diabetic rats (Figure-9).
The 5-HTT antibody staining in the hippocampus
showed significant decrease (p < 0.001) in the 5-HTT in
diabetic rats compared to control. There was a signifi-
cant reversal to near control level in expression of D+I
(p < 0.001), DIP (p < 0.001), D+A (p < 0.001) and DAP
(p < 0.001) of 5-HTT on treatment with insulin and
Aegle marmelose alone and in combination therapy with
insulin and Aegle marmelose compared to diabetic rat
(Figure-10).
Discussion
Maintenance of euglycemia over a lifetime of diabetes
cannot be accomplished safely with currently available
treatment methods [26]. The effect of hyperglycemic
episodes is visible in brain regions associated with mem-
ory, especially the hippocampus [27]. Increased blood
glucose level observed during diabetes is similar with
previous reports as a result of the marked destruction of
insulin secreting pancreatic b-cells by streptozotocin
[28]. Treatment normalised the increased blood glucose
level to control. A decrease in the rate of 5-HT synth-
esis and changes in 5-HT neurotransmission have
demonstrated to reduce 5-HT concentrations [29]. In
the brain, serotonergic fibres acts on specific receptors
to modulate the activity on autonomic pathways and
affects energy expenditure regulated by 5-HT receptors.
Serotonergic pathways also directly affect glucose home-
ostasis through regulation of autonomic efferents and
action on peripheral tissues [30].
5-HT has both depolarising and hyperpolarizing
effects in the hippocampus, via its different receptors.
Activation of 5-HT2A receptors found in the hippocam-
pus has been suggested to induce depolarization in the
dentate gyrus [31]. 5-HT2A receptor has been found to
enhance Long term potentiation in the hippocampus
[32]. The changes in brain 5-HT synthesis rate in
diabetic rats are related to the various behavioural and
psychological changes. The psychological changes observed
in diabetes appear to persist even when the diabetic
state is well-controlled with insulin administration [33].
Previous reports showed a decrease in 5-HT in brain
r e g i o n sd u r i n gd i a b e t e s[ 2 9 ] .5 - H I A A / 5 - H Tt u r n o v e r
ratio showed an increase in diabetes. In hippocampus,
inactive decarboxylation reaction due to lack of pyri-
doxal phosphate decreased the conversion to 5-HT.
Treatment of rats with moderate doses of pyridoxine
results in an increment in brain 5-HT indicating that
the tissue 5-HTP decarboxylation responds to the pyri-
doxine status of the animal [34]. Present study indicates
a decreased 5-HT and 5-HT2A receptor binding with
increase in affinity in hippocampus of diabetic rats. This
decrease in the sympathetic activity thereby decreases
the circulating 5-HT level. Treatment of pyridoxine
along with Aegle marmelose a n di n s u l i n ,r e s u l t e di n
restoring the synthesis of 5-HT in hippocampus of
diabetic rats. 5-HT levels reflect the intrasynaptic release
indicated by the response of the Bmax of 5-HT receptor
binding to its ligand. The results indicate that the pyri-
doxal phosphate content in hippocampus regulates the
extent of decarboxylation of the 5-HTP, the precursor
of 5-HT. Treatment of diabetic rats with pyridoxine
reflected the synthesis and secretion into the synaptic
cleft of the neurotransmitter 5-HT [35,36]. 5-HT synth-
esis is increased, possibly as a result of desensitization of
receptors [37] and thereby modifying synthesis and
release of 5-HT.
5-HTT regulates the entire serotonergic system and its
receptors via modulation of its expression and function.
In brain, 5-HTT is situated both in presynaptic mem-
branes of nerve terminals in proximity to serotonin-
containing cell bodies [38]. 5-HTT mediates rapid
removal and recycling of released 5-HT following neu-
ronal stimulation. Thus, it has a critical role in the
homeostatic regulation of the signals reaching 5-HT
receptors. 5-HTT is important in emotion regulation
and social behaviour, drawing from an interdisciplinary
perspective of behavioural genetics and cognitive neu-
roscience. Integration of these findings suggest that the
5-HTT gene has an impact on behaviour and have a
role in social cognition [39]. 5-HT is packaged into vesi-
cles for synaptic exocytosis. Extracellular 5-HT signals
through 5-HT2A receptors. Synaptic 5-HT signaling are
motivated by uptake of 5-HT2A from the synapse by 5-
HTT.
Recent evidence suggests that a dysfunction of the
neuronal insulin receptor signalling cascade, with the
subsequent abnormalities in glucose/energy metabolism,
affect amyloid precursor protein metabolism and cause
Table 3 [
3H] Ketanserin binding parameters in the
hippocampus of control and experimental rats
Experimental Groups Bmax
(fmoles/mg protein)
Kd (nM)
Control 260.5 ± 0.35 0.68 ± 0.08
Diabetic 176.2 ± 0.19
b 0.77 ± 0.17
a
Diabetic + Insulin 218.1 ± 0.32
d 0.67 ± 0.09
c
Diabetic + Pyridoxine 180.6 ± 0.27
b 0.70 ± 0.06
c
Diabetic + Insulin+ Pyridoxine 244.0 ± 0.26
d 0.68 ± 0.11
c
Diabetic+A. marmelose 209.3 ± 0.22
d 0.68 ± 0.11
c
Diabetic+ A. marmelose
+Pyridoxine
228.2 ± 0.29
d 0.67 ± 0.07
c
Values are mean ± S.E.M of 6-8 separate experiments. Each group consists of
6-8 rats.
a p < 0.05,
b p < 0.001 when compared to control;
c p < 0.05,
d p < 0.001 when compared to diabetic group.
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Figure 3 a, b Representative graph showing Scatchard analysis of [
3H] Ketanserin binding against ketanserin in the hippocampus of
control and experimental rats.B max – Maximal Binding (fmol/mg protein), Kd – dissociation constant (nM). Values are mean ± S.E.M of 4-6
separate experiments. Each group consists of 6-8 rats.
a p < 0.05,
b p < 0.001 when compared to control;
c p < 0.05,
d p < 0.001 when compared
to diabetic group. Incubation was done with 0.1 nM-2.5 nM at 37 °C of [
3H] Ketanserin in a total incubation volume of 250 μl. 10 μM unlabelled
ketanserin was used to determine the nonspecific binding. The reaction was stopped by rapid filtration through GF/B filters using ice cold
Washing Buffer pH 7.6. Bound radioactivity was counted with cocktail-T in a Wallac 1409 liquid scintillation counter.
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Page 8 of 15insulin dysfunction [40]. In this study the altered expres-
sion of insulin receptor expression in the hippocampus
of diabetic rats was reversed to near control by treat-
ment with insulin and Aegle marmelose alone and in
combination with pyridoxine. The distribution of insulin
receptors in the brain and the presence of insulin-
dependent glucose transporters suggest that brain insu-
lin participate in several cognitive functions, including
learning and memory [41]. In animal models of diabetes,
impairments of spatial learning occur in association with
distinct changes in hippocampal synaptic plasticity due
to defects in insulin action in the brain [42]. Treatment
with insulin therefore not only corrects hyperglycaemia,
but also directly affects the brain. One problem is that
exogenous insulin injection reduces blood glucose and
lead to hypoglycaemia that is associated with impaired
-0.7
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Figure 4 Representative graph showing Real Time amplification of 5-HT2A mRNA from the hippocampus of control and experimental
rats. are mean ± S.E.M of 4-6 rats in each group. Each group consists of 6-8 rats.
a p < 0.001 when compared to control group,
b p < 0.001
when compared to diabetic group. The relative ratios of mRNA levels were calculated using the ΔΔCT method normalized with b-actin CT-value
as the internal control and Control CT-value as the calibrator.
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Figure 5 Representative graph showing Real Time amplification of 5-HTT mRNA from the hippocampus of Control and experimental
rats. are mean ± S.E.M of 4-6 rats in each group. Each group consists of 6-8 rats.
a p < 0.05,
b p < 0.001 when compared to control group,
cp <
0.001 when compared to diabetic group. The relative ratios of mRNA levels were calculated using the ΔΔCT method normalized with b-actin CT-
value as the internal control and Control CT-value as the calibrator.
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Page 9 of 15memory [43]. Cognitive impairments associated with
diabetes caused by inadequate insulin/insulin receptor
functions have also been documented [44]. The role of
insulin as a regulator for cell proliferation has already
b e e ne s t a b l i s h e d[ 4 5 ] .I tw a so b s e r v e df r o mt h ee a r l i e r
studies that administration of pyridoxine along with
insulin serves as a control measure for diabetes, regulat-
ing GDH activity and glucose level [14]. The reversal of
hyperglycaemic condition in DIP treatment group is due
to the effect of pyridoxine and insulin on pancreatic
b cells. Treatment with pyridoxine to diabetic rats
caused a reversal in the Bmax of 5-HT2A receptors to
near control level. Also, it is evident that pyridoxine
along with insulin and Aegle marmelose leaf extract has
neuroprotective action mediated through the 5-HTT at
the transcription level.
Figure 6 Representative graph showing Real Time amplification of INSR mRNA from the hippocampus of Control and experimental
rats. are mean ± S.E.M of 4-6 rats in each group. Each group consists of 6-8 rats.
a p < 0.05,
b p < 0.001 when compared to control group,
cp <
0.001 when compared to diabetic group. The relative ratios of mRNA levels were calculated using the ΔΔCT method normalized with b-actin CT-
value as the internal control and Control CT-value as the calibrator.
a
d
a,c 
d d
d
Figure 7 Representative graph showing behavioural response in streptozotocin induced diabetic Rats: Effects of insulin and
pyridoxine treatment and Closed Arm Entry attempts (Counts/5 minutes) in Elevated plus- maze test by of control and experimental
rats. Values are mean ± S.E.M of 4-6 separate experiments. Each group consists of 6-8 rats.
a p < 0.001 when compared to control group;
c p < 0.01,
d p < 0.001 when compared to diabetic group.
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Page 10 of 15Aegle marmelose was comparable to insulin in rever-
sing blood glucose to normal levels. Anandharajan et
al. [46] reported that Aegle marmelose activate glucose
transport in PI3 kinase-dependent fashion. Scopoletin
(7-hydroxy-6-methoxy coumarin) isolated from leaves
of Aegle marmelose was evaluated for its potential to
regulate hyperglycemia in rats [47]. Alkaloidal-amide
Aegeline isolated from leaves of Aegle marmelose is
found to have anti-hyperglycemic activity by lowering
the blood glucose [46]. The leaf extract treated animals
appeared healthier and were less prone to the frequent
hypoglycaemic condition observed in their insulin trea-
ted counter parts. Previous studies by Sharma et al.
[48] the plant extract enhance glucose utilization since
it significantly decreased the blood glucose level. This
fact attributed to potentiating of insulin effect of
plasma by increasing the pancreatic secretion of insulin
from existing b-cell or its release from bound insulin
intercede by increase in the insulin receptor. Treat-
ment with pyridoxine alone and in combination with
insulin and Aegle marmelose to diabetic rats caused a
reversal in the Bmax of 5-HT, 5-HT2A receptors and
gene expression to near control level. Also, it is evi-
dent that Aegle marmelose has a role in controlling
INSR function. This study demonstrates the involve-
ment of 5-HT2A receptor which has modulating effect
on the diabetes stress. Administration of pyridoxine
alone and in combination with Aegle marmelose and
insulin significantly decrease dt h ed i a b e t i ca s s o c i a t e d
stress. Hence the treatment has pharmacological and
neurobiological basis.
The change in brain 5-HT synthesis rate in diabetic
animals is related to the various behavioural and
psychological changes [49]. Anxiety is a neurological
problem associated with diabetes mellitus. Muneoka and
colleagues [50] revealed the correlation between diabetic
anxiety and serotonergic systems. There is a decrease in
t h es e r o t o n e r g i cr e s p o n s et os t r e s s f u ls t i m u l ia n dt h e
dysfunction of stress-elicited 5-HT release caused the
increased expression of fear-related behaviour in dia-
betic rats [51]. Investigation on elevated plus maze and
spontaneous alternation in behaviour paradigm as a
measure of anxiety. Our findings support impaired
hippocampal plasticity and cognition induced by diabetes.
Diabetic rats showed an increased percentage attempt
made towards open arm entry and the animal also
remained for longer period in closed arms of elevated
plus-maze maze thereby causing hypo locomotion in
diabetic rats. The treatment reversed the behavioural
deficit in diabetic rats to near control. The possible
anxiolytic effect is related to its effect on serotonergic
transmission [52]. Thus perturbations of the 5-HT
receptor system directly modulate stress susceptibility
rendering them anxiogenic as well as depressive profile.
A decrease in general exploratory activity in an open
arena after restraint stress has been previously described
[37]. In the elevated plus-maze studies found a decrease
in the percentage of open arm entries and/or time spent
a
a
c
c
d
c
c c
c
Figure 8 Representative graph showing behavioural response in streptozotocin induced diabetic Rats: Effects of insulin and
pyridoxine treatment in Time Spent in Open Arm Entry attempts (Counts/5 minutes) by control and experimental rats in Elevated
plus- maze test by of control and experimental rats. Values are mean ± S.E.M of 4-6 separate experiments. Each group consists of 6-8 rats.
a
p < 0.001 when compared to control group;
c p < 0.01,
d p < 0.001 when compared to diabetic group.
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Page 11 of 15Figure 9 Confocal image of 5-HT2A receptors in the hippocampus of control and Experimental rats using immunofluorescent 5-HT2A
receptor specific primary antibody and FITC as secondary antibody. The pixel intensity of The pixel intensity of control - 384132 ± 1454,
diabetic - 133475 ± 1431
a, diabetic+Insulin - 229123 ± 1453
a, c, diabetic+pyridoxine - 151012 ± 2662
a, b, diabetic+insulin+pyridoxine - 398791
± 2105
c, diabetic+Aegle marmelose - 222921 ± 1097
a, c and diabetic+Aegle marmelose+pyridoxine - 314997 ± 1084
c. Values are mean ± S.E.M of
4-6 rats in each group. Each group consists of 6-8 rats.
a p < 0.001 when compared to control group;
b p < 0.05,
c p < 0.001 when compared to
diabetic group. There was significant reversal of 5-HT2A receptor to near control level on treatment with pyridoxine alone and in combination
therapy with insulin and Aegle marmelose compared to diabetic rats. Arrow in white shows 5-HT2A receptors.
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Diabetic+A. marmelose+Pyridoxine
Figure 10 Confocal image of 5-HTT receptors in the hippocampus of control and Experimental rats using immunofluorescent 5-HTT
receptor specific primary antibody and FITC as secondary antibody. The pixel intensity of control - 4235653 ± 1960, diabetic - 2833408 ±
1978
a, diabetic+Insulin - 3964668 ± 1670
a, b, diabetic+pyridoxine - 2897587 ± 3426
a, diabetic+insulin+pyridoxine - 4121017 ± 2723
b, diabetic
+Aegle marmelose - 3866844 ± 1534
a, b and diabetic+Aegle marmelose+pyridoxine - 4098789 ± 2086
b. Values are mean ± S.E.M of 4-6 rats in
each group. Each group consists of 6-8 rats.
a p < 0.001 when compared to control group;
b p < 0.001 when compared to diabetic group. There
was significant reversal of 5-HTT receptor to near control level on treatment with pyridoxine alone and in combination therapy with insulin and
Aegle marmelose compared to diabetic rats. Arrow in white shows 5-HTT.
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Page 13 of 15in them [6,29]. This study demonstrates the involvement
of 5-HT receptor which has modulating effect on the
diabetes and associated motor defects. Cools et al. [53]
s u g g e s tt h a ts e r o t o n e r g i cr e ceptor function resolve the
essential inconsistency in hippocampus associated with
depression. Administration of pyridoxine and insulin
significantly increased the percentage of open arm
entries and the number of total entries. Hence the treat-
ment has pharmacological and neurobiological bases of
anxiety.
The prevalence of diabetes among depressed and
anxious patients is due to high sensitivity of diabetics to
the adverse effects of stress, etiology and course of the
disease. Serotonergic system and insulin function play
key roles in the regulation of stress-related behaviours.
The result of this study has demonstrated the effect of
insulin, Aegle marmelose leaf extract alone and in com-
bination with pyridoxine has marked to normalize
5-HT, 5-HT2A receptor, gene expression studies along
with the Elevated plus test implicate a role in reducing
the stress associated with diabetic rats. Thus it is sug-
gested that pyridoxine treated alone and in combination
with insulin and Aegle marmelose have a functional role
through serotonergic receptors regulation in the hippo-
campus. This represents a possibility for the better man-
agement of diabetic mediated neurological complications.
Abbreviations
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